279 related articles for article (PubMed ID: 36561716)
1. Comparing clinical characteristics of systemic sclerosis with or without interstitial lung disease: A cross-sectional study from a single center of the Chinese Rheumatism Data Center.
Li H; Zhang X; Yu L; Shang J; Fan J; Feng X; Zhang R; Ren J; Guo Q; Duan X
Front Med (Lausanne); 2022; 9():1061738. PubMed ID: 36561716
[TBL] [Abstract][Full Text] [Related]
2. Elevated serum Krebs von den Lungen-6 in systemic sclerosis: a marker of lung fibrosis and severity of the disease.
Benyamine A; Heim X; Resseguier N; Bertin D; Gomez C; Ebbo M; Harlé JR; Kaplanski G; Rossi P; Bardin N; Granel B
Rheumatol Int; 2018 May; 38(5):813-819. PubMed ID: 29455320
[TBL] [Abstract][Full Text] [Related]
3. Platelet-to-lymphocyte ratio and neutrophil-to-lymphocyte ratio as potential makers for digital ulcers and interstitial lung disease in patients with systemic sclerosis: cross-sectional analysis of data from a prospective cohort study.
Kim A; Kim Y; Kim GT; Ahn E; So MW; Sohn DH; Lee SG
Rheumatol Int; 2020 Jul; 40(7):1071-1079. PubMed ID: 32424613
[TBL] [Abstract][Full Text] [Related]
4. Clinical phenotype in scleroderma patients based on autoantibodies.
Santos CS; Morales CM; Castro CÁ; Álvarez ED
Rheumatol Adv Pract; 2023 Apr; 7(Suppl 1):i26-i33. PubMed ID: 36968636
[TBL] [Abstract][Full Text] [Related]
5. Contribution of Left Ventricular Diastolic Dysfunction to Survival and Breathlessness in Systemic Sclerosis-Associated Interstitial Lung Disease.
Fairley JL; Hansen D; Burns A; Prior D; La Gerche A; Morrisroe K; Stevens W; Nikpour M; Ross LJ
J Rheumatol; 2024 May; 51(5):495-504. PubMed ID: 38224991
[TBL] [Abstract][Full Text] [Related]
6. Clinical features of patients with systemic sclerosis positive for anti-SS-A antibody: a cohort study of 156 patients.
Watanabe T; Ototake Y; Akita A; Suzuki M; Kanaoka M; Tamura J; Saigusa Y; Yamaguchi Y
Arthritis Res Ther; 2024 May; 26(1):93. PubMed ID: 38702799
[TBL] [Abstract][Full Text] [Related]
7. Prevalence and risk factors for left ventricular diastolic dysfunction in systemic sclerosis: a multi-center study of CRDC cohort in China.
Hui M; Zhou J; Zhang L; Duan X; Li M; Wang Q; Zhao J; Hou Y; Xu D; Zeng X
Clin Rheumatol; 2021 Nov; 40(11):4589-4596. PubMed ID: 34142296
[TBL] [Abstract][Full Text] [Related]
8. Serum levels of Krebs von den Lungen-6 as a promising marker for predicting occurrence and deterioration of systemic sclerosis-associated interstitial lung disease from a Chinese cohort.
Cao XY; Hu SS; Xu D; Li MT; Wang Q; Hou Y; Zeng XF
Int J Rheum Dis; 2019 Jan; 22(1):108-115. PubMed ID: 30592376
[TBL] [Abstract][Full Text] [Related]
9. Incidence and predictors of interstitial lung disease (ILD) in Thai patients with early systemic sclerosis: Inception cohort study.
Wangkaew S; Euathrongchit J; Wattanawittawas P; Kasitanon N; Louthrenoo W
Mod Rheumatol; 2016 Jul; 26(4):588-93. PubMed ID: 26561397
[TBL] [Abstract][Full Text] [Related]
10. Clinical Relevance of the Serial Measurement of Krebs von den Lungen-6 Levels in Patients with Systemic Sclerosis-Associated Interstitial Lung Disease.
Shirai Y; Fukue R; Kaneko Y; Kuwana M
Diagnostics (Basel); 2021 Oct; 11(11):. PubMed ID: 34829353
[TBL] [Abstract][Full Text] [Related]
11. Clinical Features and Risk Factors of Rapidly Progressive Systemic Sclerosis in a Single Center in China: Anti-RNA Polymerase III Antibodies as a Predictor.
Yu Q; Zhang J; Fan L; Yu T; Liu B; Ding J
Discov Med; 2023 Apr; 35(175):193-200. PubMed ID: 37105929
[TBL] [Abstract][Full Text] [Related]
12. Interstitial lung disease in systemic sclerosis: data from the spanish scleroderma study group.
Sánchez-Cano D; Ortego-Centeno N; Callejas JL; Fonollosa Plá V; Ríos-Fernández R; Tolosa-Vilella C; Espinosa-Garriga G; Colunga-Argüelles D; Egurbide-Arberas MV; Rubio-Rivas M; Freire M; Ríos-Blanco JJ; Trapiella-Martínez L; Rodríguez-Carballeira M; Marín-Ballvé A; Pla-Salas X; Simeón-Aznar CP
Rheumatol Int; 2018 Mar; 38(3):363-374. PubMed ID: 29322341
[TBL] [Abstract][Full Text] [Related]
13. Clinical characteristics and survival of pulmonary arterial hypertension with or without interstitial lung disease in systemic sclerosis.
Fairley JL; Hansen D; Ross L; Proudman S; Sahhar J; Ngian GS; Walker J; Host LV; Morrisroe K; Apostolopoulous D; Ferdowsi N; Wilson M; Tabesh M; Stevens W; Nikpour M;
Arthritis Res Ther; 2023 May; 25(1):77. PubMed ID: 37173780
[TBL] [Abstract][Full Text] [Related]
14. Anti-Ro52 positivity is associated with progressive interstitial lung disease in systemic sclerosis-an exploratory study.
Hamberg V; Sohrabian A; Volkmann ER; Wildt M; Löfdahl A; Wuttge DM; Hesselstrand R; Dellgren G; Westergren-Thorsson G; Rönnelid J; Andréasson K
Arthritis Res Ther; 2023 Sep; 25(1):162. PubMed ID: 37667402
[TBL] [Abstract][Full Text] [Related]
15. Kinetic changes in serum KL-6 levels predict disease progression in patients with systemic sclerosis-associated interstitial lung disease.
Watanabe S; Kase K; Saeki K; Ohkura N; Murata A; Waseda Y; Takato H; Ichikawa Y; Yasui M; Kasahara K
Respir Med; 2022 Jan; 191():106689. PubMed ID: 34844174
[TBL] [Abstract][Full Text] [Related]
16. Nintedanib in Patients With Systemic Sclerosis-Associated Interstitial Lung Disease: Subgroup Analyses by Autoantibody Status and Modified Rodnan Skin Thickness Score.
Kuwana M; Allanore Y; Denton CP; Distler JHW; Steen V; Khanna D; Matucci-Cerinic M; Mayes MD; Volkmann ER; Miede C; Gahlemann M; Quaresma M; Alves M; Distler O
Arthritis Rheumatol; 2022 Mar; 74(3):518-526. PubMed ID: 34514739
[TBL] [Abstract][Full Text] [Related]
17. Clinical phenotypes, hemodynamic characteristics and prognosis of Chinese patients with systemic sclerosis-associated precapillary pulmonary hypertension: a retrospective study.
Yuan YP; Yuan P; Su YL; Jiang R; Zhang R; He J; Qiu HL; Luo CJ; Liu JM; Gong SG; Wang L; Zhao QH
Clin Rheumatol; 2022 Jun; 41(6):1675-1686. PubMed ID: 35099674
[TBL] [Abstract][Full Text] [Related]
18. Clinical and autoantibody profiles of systemic sclerosis patients: A cross-sectional study from North India.
Ghosh S; Tanna D; Telang K; Dhuria S; Gupta R
Indian J Dermatol Venereol Leprol; 2023 Jul; ():1-7. PubMed ID: 37436007
[TBL] [Abstract][Full Text] [Related]
19. Interstitial Lung Disease in Systemic Sclerosis: A Single-center Retrospective Analysis.
Yayla ME; Balcı G; Torgutalp M; Eroğlu DŞ; Dinçer ABK; Gülöksüz EGA; Sezer S; Yüksel ML; Ateş A; Turgay TM; Kınıklı G
Curr Rheumatol Rev; 2022; 18(2):150-156. PubMed ID: 34517806
[TBL] [Abstract][Full Text] [Related]
20. Clinical Characteristics of Systemic Sclerosis With Interstitial Lung Disease.
Jung E; Suh CH; Kim HA; Jung JY
Arch Rheumatol; 2018 Sep; 33(3):322-327. PubMed ID: 30632529
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
